Last updated: 2026-02-12 15:48:17 ET
The new shot was not compared to “the best-available standard of care in the United States at the time of the study,” an FDA official told Moderna...
When enterprises fine-tune LLMs for new tasks, they risk breaking everything the models already know. This forces companies to maintain separate model...
A high level of abrasion resistance means a Rhino Grid can outwear materials like rubbers, plastics, and metals by greater margins. This toughness mak...
Presented by Cisco AI agents are breaking traditional IT operations models, adding complexity, data silos, and fragmented workflows. DJ Sampath, Cisco...
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with mRNA technology
Moderna said the move is inconsistent with previous feedback from the FDA on the experimental influenza shot, called mRNA-1010.
Until recently, the practice of building AI agents has been a bit like training a long-distance runner with a thirty-second memory. Yes, you could giv...
Robo.ai Inc. (NASDAQ:AIIO) shares are up on Tuesday after the company announced a joint venture with DaBoss.AI Inc. in the UAE to build a distributed ...
Network Rail has secured planning approval for the redevelopment of London's Liverpool Street Station after officers accepted heritage harm on the bas...
